Breaking News, Collaborations & Alliances

JS Bio and Etta Biotech Advancing Partnership

Will set up a high titer transient protein expression platform for high quality protein production.

By: Contract Pharma

Contract Pharma Staff

Jianshun Biosciences (JS Bio) recently formed its strategic partnership with Etta Biotech to set up a high titer transient protein expression platform for high quality protein production using JS Bio’s transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech’s transient transfection high titer protein expression platform.   Etta Biotech is a leading cell electroporation technology and equipment supplier. Its proprietary large-capacity flow electroporator,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters